Home »

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).

Apr 17, 2023


  • Matteo Santoni

    Oncology Unit, Macerata Hospital, Macerata, Italy.

    Francesco Massari

    Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia. Electronic address:

    Zin W Myint

    Markey Cancer Center, University of Kentucky, Lexington, KY.

    Roberto Iacovelli

    Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

    Martin Pichler

    Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

    Umberto Basso

    Oncology 3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.

    Jindrich Kopecky

    Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

    Jakub Kucharz

    Department of Uro-oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.

    Sebastiano Buti

    Medical Oncology Unit, University Hospital of Parma – Department of Medicine and Surgery, University of Parma, Parma, Italy.

    Alessia Salfi

    Oncology Unit 2, University Hospital of Pisa, Pisa, Italy.

    Thomas Büttner

    Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.

    Ugo De Giorgi

    Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy.

    Ravindran Kanesvaran

    Division of Medical Oncology, National Cancer Centre Singapore, Singapore.

    Ondřej Fiala

    Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

    Enrique Grande

    Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.

    Paolo Andrea Zucali

    Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano – Milan, Italy.

    Giuseppe Fornarini

    IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

    Maria T Bourlon

    Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

    Sarah Scagliarini

    UOC di Oncologia, Azienda Ospedaliera di Rilievo Nazionale Cardarelli di Napoli, Naples, Italy.

    Javier Molina-Cerrillo

    Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.

    Gaetano Aurilio

    Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.

    Marc R Matrana

    Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA.

    Renate Pichler

    Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.

    Carlo Cattrini

    Department of Medical Oncology, “Maggiore della Carità” University Hospital, Novara, Italy.

    Tomas Büchler

    Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.

    Emmanuel Seront

    Department of Medical Oncology, Centre Hospitalier de Jolimont, Belgium.

    Fabio Calabrò

    Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy.

    Alvaro Pinto

    Medical Oncology Department, La Paz University Hospital, Madrid, Spain.

    Rossana Berardi

    Department of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti delle Marche, Ancona, Italy.

    Anca Zgura

    Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

    Giulia Mammone

    Department of Radiological, Oncological and Anatomo-Pathological Science, “Sapienza” University of Rome, Rome, Italy.

    Jawaher Ansari

    Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.

    Francesco Atzori

    Unità di Oncologia Medica, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.

    Rita Chiari

    UOC Oncologia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Italy.

    Roubini Zakopoulou

    2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

    Orazio Caffo

    Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.

    Giuseppe Procopio

    Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncologia Medica, Ospedale Maggiore di Cremona, Italy.

    Maria Bassanelli

    Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy.

    Ilaria Zampiva

    Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.

    Carlo Messina

    Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.

    Zsófia Küronya

    Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.

    Alessandra Mosca

    Oncology, Candiolo Cancer Institute, IRCCS-FPO, Torino, Italy.

    Dipen Bhuva

    Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India.

    Nuno Vau

    Urologic Oncology, Champalimaud Clinical Center, Lisbon, Portugal.

    Lorena Incorvaia

    Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.

    Sara Elena Rebuzzi

    Ospedale San Paolo, Medical Oncology, Savona, Italy; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.

    Giandomenico Roviello

    Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.

    Ignacio Ortego Zabalza

    Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.

    Alessandro Rizzo

    Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico “Don Tonino Bello”, I.R.C.C.S. Istituto Tumori “Giovanni Paolo II”, Bari, Italy.

    Veronica Mollica

    Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.

    Ilaria Catalini

    Oncology Unit, Macerata Hospital, Macerata, Italy.

    Fernando Sabino M Monteiro

    Latin American Cooperative Oncology Group – LACOG; Oncology and Hematology Department, Hospital Santa Lucia, Brasília, Federal District, Brazil.

    Rodolfo Montironi

    Molecular Medicine and Cell Therapy Foundation, Polytechnic University of the Marche Region, Ancona, Italy.

    Nicola Battelli

    Oncology Unit, Macerata Hospital, Macerata, Italy.

    Mimma Rizzo

    Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.

    Camillo Porta

    Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy; Chair of Oncology, Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, Bari, Italy.




PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


View all newsletters